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Background
With the recent emergence of the bird flu in many Euro-
pean countries, molecular biologists are challenged more
then ever to advance the present methods of vaccine
development. We have developed a method that is based
on the following key elements: safety, efficacy and rapid-
ity. Influenza A virus like particles (VLP) were generated in
insect cells by co-transfection of especially designed plas-
mids. In order to produce VLPs, four recombinant baculo-
viruses were generated each containing two influenza
genes under control of the Autographa californica multiple
nuclear polyhedrosis virus (AcMNPV) pH and p10 pro-
motors for high level expression in Sf9 insect cells. VLPs
contained 8 of 10 influenza A virus proteins of strain PR8,
missing NS1 and NS2. Alternatively, VLPs were generated,
by assembly of just three proteins, HA, NA and M1, which
are responsible for induction of the immune system in
vivo. All influenza genes have been produced from syn-
thetical oligonucleotides, using a rapid thermocycler, the
PCRJet®. Synthetic genes of new emerging influenza A var-
iants can be produced accurately and rapidly by using this
technology. Recombinant baculoviruses were generated
using the Bac-to-Bac system by homologous recombina-
tion between a transfervector and the baculoviral shuttlev-
ector (bacmid) in DH10Bac cells. By optimizing DNA
synthesis and gene transfer into Sf9 cells, we anticipate
major improvements in flexibility, speed and yield of
influenza vaccine production as compared to available
technologies.
Results
Co-transfection of bacmids resulted in the generation of
influenza A virus like particles in the supernatant of Sf9
cells. VLPs were purified by means of Sucrose gradient
centrifugation and the expected results were confirmed by
Electron microscopy, Western Blot analysis and hemag-
glutination assays.
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